Feasibility of microdialysis to determine interstitial rocuronium concentration in the muscle tissue of anesthetized neurosurgical patients

Journal of Neurosurgical Anesthesiology

Volumn 22, Issue 2, 2010, Pages 163-169

  Fernández Candil, Juan ^a   Gambús, Pedro L ^a   Trocóniz, Iñaki F ^b   Valero, Ricard ^a   Carrero, Enrique ^a   Fabregas, Neus ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN; ROCURONIUM;

ADULT; AGED; ARTICLE; BRAIN SURGERY; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG MECHANISM; DRUG MUSCLE LEVEL; FEMALE; GOOD CLINICAL PRACTICE; HUMAN; IN VITRO STUDY; INTERSTITIUM; LONG TERM CARE; MALE; MICRODIALYSIS; MUSCLE TISSUE; NEUROSURGERY; PRIORITY JOURNAL;

ADULT; AGED; ANDROSTANOLS; ANESTHESIA; ANTICONVULSANTS; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MICRODIALYSIS; MIDDLE AGED; MONITORING, INTRAOPERATIVE; MUSCLE, SKELETAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; NEUROSURGICAL PROCEDURES; OROSOMUCOID; PHENYTOIN; SERUM ALBUMIN; YOUNG ADULT;

EID: 77949966782     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e3181c80a68     Document Type: Article

References (31)

1. Booij LH, Knape HT. The neuromuscular blocking effect of Org9426. A new intermediately-acting steroidal non-depolarising muscle relaxant in man. Anaesthesia. 1991;46:341-343.
2. Proost JH, Eriksson LI, Mirakhur RK, et al. Urinary, biliary and faecal excretion of rocuronium in humans. Br J Anaesth. 2000;85: 717-723.
3. Soriano SG, Martyn JA. Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance. Clin Pharmacokinet. 2004;43:71-81.
4. Araki H, Ogake N, Minami S, et al. Application of muscle microdialysis to evaluate the concentrations of the fluoroquinolones pazufloxacin and ofloxacin in the tissue interstitial fluids of rats. J Pharm Pharmacol. 1997;49:1141-1144.
5. Hansen DK, Davies MI, Lunte SM, et al. Pharmacokinetic and metabolism studies using microdialysis sampling. J Pharm Sci. 1999;88:14-27.
6. Tegeder I, Schmidtko A, Brautigam L, et al. Tissue distribution of imipenem in critically ill patients. Clin Pharmacol Ther. 2002;71: 325-333.
7. Globus MY, Busto R, Dietrich WD, et al. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis. J Neurochem. 1988;51: 1455-1464.
8. Kendrick KM, Leng G. Haemorrhage-induced release of noradrenaline, 5-hydroxytryptamine and uric acid in the supraoptic nucleus of the rat, measured by microdialysis. Brain Res. 1988;440: 402-406.
9. Hammarlund-Udenaes M, Paalzow LK, De Lange EC. Drug equilibration across the blood-brain barrier-pharmacokinetic considerations based on the microdialysis method. Pharm Res. 1997;14: 128-134.
10. Hammarlund-Udenaes M. The use of microdialysis in CNS drug delivery studies. Pharmacokinetic perspectives and results with analgesics and antiepileptics. Adv Drug Deliv Rev. 2000;45:283-294.
11. Hernandez-Palazon J, Tortosa JA, Martinez-Lage JF, et al. Rocuronium-induced neuromuscular blockade is affected by chronic phenytoin therapy. J Neurosurg Anesthesiol. 2001;13:79-82.
12. Fernadez-Candil J, Gambus PL, Troconiz IF, et al. Pharmacokinetic- pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery. Eur J Clin Pharmacol. 2008;64:795-806.
13. Alloul K, Whalley DG, Shutway F, et al. Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients. Anesthesiology. 1996;84: 330-339.
14. Wright PM,McCarthy G, Szenohradszky J, et al. Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium. Anesthesiology. 2004;100:626-633.
15. Ungerstedt U. Microdialysis-principles and applications for studies in animals and man. J Intern Med. 1991;230:365-373.
16. Chaurasia CS, Muller M, Bashaw ED, et al. AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives. Pharm Res. 2007;24:1014-1025.
17. Roy JJ, Varin F. Physicochemical properties of neuromuscular blocking agents and their impact on the pharmacokinetic-pharmacodynamic relationship. Br J Anaesth. 2004;93:241-248.
18. Fuchs-Buder T, Claudius C, Skovgaard LT, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007;51:789-808.
19. Viby-Mogensen J, Ostergaard D, Donati F, et al. Pharmacokinetic studies of neuromuscular blocking agents: good clinical research practice (GCRP). Acta Anaesthesiol Scand. 2000;44:1169-1190.
20. Kleef UW, Proost JH, Roggeveld J, et al. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates. J Chromatogr. 1993;621:65-76.
21. De Lange EC, De Boer AG, Breimer DD. Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv Drug Deliv Rev. 2000;45:125-148.
22. Ezzine S, Yamaguchi N, Varin F. Determination of interstitial rocuronium concentrations in the muscle tissue of anesthetized dogs by microdialysis. J Pharmacol Toxicol Methods. 2004;49: 121-129.
23. Ezzine S, Varin F. Interstitial muscle concentrations of rocuronium under steady-state conditions in anaesthetized dogs: actual versus predicted values. Br J Anaesth. 2005;94:49-56.
24. Jellish WS, Thalji Z, Brundidge PK, et al. Recovery from mivacurium-induced neuromuscular blockade is not affected by anticonvulsant therapy. J Neurosurg Anesthesiol. 1996;8:4-8.
25. Ornstein E, Matteo RS, Schwartz AE, et al. The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium. Anesthesiology. 1987;67: 191-196.
26. Richard A, Girard F, Girard DC, et al. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Anesth Analg. 2005; 100:538-544.
27. Soriano SG, Sullivan LJ, Venkatakrishnan K, et al. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. Br J Anaesth. 2001;86:223-229.
28. Spacek A, Neiger FX, Krenn CG, et al. Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. Anesthesiology. 1999;90:109-112.
29. Tempelhoff R,Modica PA, JellishWS, et al. Resistance to atracuriuminduced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg. 1990;71:665-669.
30. MacFarlane IA, Rosenthal FD. Severe myopathy after status asthmaticus. Lancet. 1977;2:615.
31. Gehr LC, Sessler CN. Neuromuscular blockade in the intensive care unit. Semin Respir Crit Care Med. 2001;22:175-188.